Search for authorsSearch for similar articles
1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Evaluation of dabigatran, rivaroxaban and apixaban target-specific assays in a multicenter French study.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dabigatran etexilate, rivaroxaban and apixaban (DOACs) are widely used and measurement of their concentration is desirable in certain clinical situations. Target-specific assays are available but limited information exists on their performance especially in their ability to accurately measure low and high concentrations.

          Related collections

          Author and article information

          Journal
          Thromb Res
          Thrombosis research
          Elsevier BV
          1879-2472
          0049-3848
          Oct 2017
          : 158
          Affiliations
          [1 ] INSERM UMR_S1140, Faculté de Pharmacie, Paris, France; Laboratoire d'Hématologie, Centre Hospitalier Universitaire, Rennes, France. Electronic address: isabelle.gouin@chu-rennes.fr.
          [2 ] Laboratoire d'Hématologie, Centre Hospitalier Universitaire, Bordeaux, France.
          [3 ] Unité d'Hémostase, Centre Hospitalier Universitaire, Dijon, France.
          [4 ] Hémostase et transfusion, Centre Hospitalier Universitaire, Lille, France; UMR_S1011, Faculté de Médecine Pôle Recherche, Université de Lille Nord de France, Lille, France.
          [5 ] Laboratoire de Pharmacologie -Toxicologie, Centre Hospitalier Universitaire, Saint-Etienne, France; Groupe de Recherche sur la Thrombose, Université Jean Monnet, Saint-Etienne, France.
          [6 ] Biostatistics, AP-HP, Pitié-Salpêtriere University Hospital, Paris, France.
          [7 ] Hematologie-Hemostase, Centre Hospitalier Universitaire, Tours, France.
          [8 ] Hematology Laboratory, Toulouse University Hospital, Toulouse, France.
          Article
          S0049-3848(17)30479-6
          10.1016/j.thromres.2017.09.001
          28892657
          8a2fd24d-3643-4386-b8e5-591e8692796d
          Copyright © 2017 Elsevier Ltd. All rights reserved.
          History

          Anti-Xa activity,DOAC measurement,Dilute thrombin time,Direct factor Xa inhibitor,Direct thrombin inhibitor,Ecarin assay,PT,aPTT

          Comments

          Comment on this article